Pretargeted radioimmunotherapy (PRIT) in progressive medullary thyroid cancer (MTC) using bispecific antibody and iodine 131-labeled bivalent hapten:: Preliminary results of a phase II clinical trial

被引：0

作者：

Salaun, P-Y ^{[1
,7
]}

Bournaud, C. ^{[2
]}

Oudoux, A. ^{[1
]}

Bardet, S. ^{[3
]}

Vuillez, J-P ^{[4
]}

Taieb, D. ^{[5
]}

Ansquer, C. ^{[1
]}

Rousseau, C. ^{[6
]}

Bridji, B. ^{[6
]}

Borson-Chazot, F. ^{[2
]}

Barbet, J. ^{[7
]}

Goldenberg, D. M. ^{[8
]}

Chatal, J-F ^{[7
]}

Kraeber-Bodere, F. ^{[1
,6
,7
]}

机构：

[1] Univ Hosp Nantes, Dept Nucl Med, Nantes, France

[2] Univ Hosp Lyon, Dept Nucl Med, Lyon, France

[3] Baclesse Canc Inst, Dept Nucl Med, Caen, France

[4] Univ Hosp Grenoble, Dept Nucl Med, Grenoble, France

[5] Univ Hosp Marseille, Dept Nucl Med, Marseille, France

[6] Gauducheau Canc Inst, Dept Nucl Med, Nantes, France

[7] INSERM, U 896, Nantes, France

[8] Ctr Mol Med & Immunol, Belleville, NJ USA

来源：

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2008年 / 23卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：524 / 524

页数：1

共 23 条

[21] [111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial
Lezaic, Luka
Erba, Paola Anna
Decristoforo, Clemens
Zaletel, Katja
Mikolajczak, Renata
Maecke, Helmut
Maina, Theodosia
Konijnenberg, Mark
Kolenc, Petra
Trofimiuk-Mueldner, Malgorzata
Przybylik-Mazurek, Elwira
Virgolini, Irene
de Jong, Marion
Froeberg, Alide C.
Rangger, Christine
Di Santo, Gianpaolo
Skorkiewicz, Konrad
Garnuszek, Piotr
Solnica, Bogdan
Nock, Berthold A.
Fedak, Danuta
Gaweda, Paulina
Hubalewska-Dydejczyk, Alicja
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (03) : 892 - 907
[22] RETRACTED: Radioimmunotherapy of small-volume disease of metastatic colorectal cancer -: Results of a phase II trial with the iodine-131-labeled humanized anti-carcinoembryonic antigen antibody hMN-14 (Retracted article. See vol. 121, pg. 2290, 2015)
Behr, TM
Liersch, T
Greiner-Bechert, L
Griesinger, F
Béhé, M
Markus, PM
Gratz, S
Angerstein, C
Brittinger, G
Becker, H
Goldenberg, DM
Becker, W
CANCER, 2002, 94 (04) : 1373 - 1381
[23] Final results of a GRAN-T-MTC phase I clinical trial using a novel CCK2 receptor-localising radiolabelled peptide probe for personalized diagnosis and therapy of patients withmetastatic medullary thyroid cancer
Lezaic, L.
Kolenc, P.
Zaletel, K.
Erba, P.
Decristoforo, C.
Mikolajczak, R.
Garnuszek, P.
Virgolini, I.
Rangger, C.
Di Santo, G.
Maecke, H.
Maina, T.
Nock, B. A.
Trofimiuk-Muldner, M.
Przybylik-Mazurek, E.
de Jong, M.
Froberg, A. C.
Konijnenberg, M.
Skorkiewicz, K.
Solnica, B.
Fedak, D.
Gaweda, P.
Hubalewska-Dydejczyk, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S181 - S181

← 1 2 3 →